Discussion Forum For Health Professionals
FDA approves first cell therapy for wrinkle-free visage
In June, after a nearly ten-year review, the US Food and Drug Administration (FDA) approved laViv (azficel-T), a first-in-class personalized cell therapy for eliminating fine wrinkles or nasolabial folds around the nose and mouth. Issued to its developer, Fibrocell Science, in Exton, Pennsylvania, the approval marks a regulatory first for ex vivo manipulated cell cosmetics in the US and could serve as a test case for future decisions on other cosmetic cell therapies.
Posted by: aftabac Posts: 271 :: 09-08-2011 :: | Reply to this Message